Skip to content
fulcrum
Contact

Supplier payment record · 02487574

Bristol-Myers Squibb Pharmaceuticals Ltd

Reported period: –

View the government filing

Average time to pay

50 days

Register median: 31 days

Invoices paid late

21%

Register median: 14%

Standard payment terms

0 to 90 days

Declared in this filing

These are company-wide, self-reported figures—not a prediction for your invoice. Comparisons use the latest filings of 1,496 companies declaring construction contracts.

Already waiting for payment?

Check your own invoice.

Use your amount and dates to estimate late-payment interest and fixed compensation.

15 filings

How payments have changed

Late payments down 1 percentage pointsCompared with the previous filing

Bristol-Myers Squibb Pharmaceuticals Ltd: share of invoices paid late (bars) and average days to pay (line), every filing since H1 180%25%50%0d30d60dH1 18H2 18H1 19H2 19H1 20H2 20H1 21H2 21H1 22H2 22H1 23H2 23H1 25H2 25H1 26BARS: PAID LATER THAN AGREEDLINE: AVERAGE DAYS TO PAY
View 6 recent filings
Recent payment filings by Bristol-Myers Squibb Pharmaceuticals Ltd
Period endingDays to payPaid lateWithin 30 daysOver 60 days
30 June 20265021%36%37%
31 December 20254522%38%29%
30 June 20255022%35%31%
31 December 20234227%41%22%
30 June 20234227%41%21%
31 December 20224024%43%20%

More from the filing

Payment terms and invoice breakdown
Standard payment terms
0 to 90 days
Maximum contractual period
90 days
Paid within 30 days
36%
Paid in 31–60 days
27%
Paid after 60 days
37%
Not paid because of a dispute
84%

The company’s own wording

The preferred BMS terms for 3rd party vendors are default to 90 days. Payment terms are outlined in contracts with suppliers. Where a contract is not negotiated, the payment terms will be clearly stated on the Purchase Orders (POs) sent to suppliers. Any changes to the payment terms would require a contract amendment. For Health Care Professionals the standard payment terms are immediate, therefore meeting these terms are difficult to achieve when we consider time to send the invoice, process, approve and release for payment, currently 73% of the above reported late payments are due to Imme…

The company’s explanation

NA
RetentionNone declared

No retention clauses were declared in this filing.

Common questions

How long does Bristol-Myers Squibb Pharmaceuticals Ltd take to pay its suppliers?

Bristol-Myers Squibb Pharmaceuticals Ltd reported an average of 50 days to pay an invoice for 1 January 2026 to 30 June 2026, with 36% of invoices paid within 30 days and 37% taking longer than 60 days. The official 2025 figure for large construction businesses is 33 days.

Does Bristol-Myers Squibb Pharmaceuticals Ltd pay late?

By its own filing, 21% of Bristol-Myers Squibb Pharmaceuticals Ltd's invoices were paid later than the agreed terms, against 14% across large construction businesses in 2025 and a median of 14% among the 1,496 companies on this register that declare construction contracts. That is down 1 points on its previous filing (22% for the period to 31 December 2025).

Does Bristol-Myers Squibb Pharmaceuticals Ltd hold retention?

Bristol-Myers Squibb Pharmaceuticals Ltd declares no retention clauses in its construction contracts in this filing. Your subcontract governs; if it holds retention, the contract terms decide when it is released.

Can I charge Bristol-Myers Squibb Pharmaceuticals Ltd interest on a late invoice?

Yes, under the Late Payment of Commercial Debts (Interest) Act 1998, from the day after the final date for payment, at 8% over the Bank of England base rate plus a fixed sum per invoice, without any clause in the contract. The calculator works it out for your figures.